Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings outcomes at this time.
Whole income elevated 3% year-over-year to $2.5 billion.
Web earnings attributable to Biogen Inc. was $266.8 million, or $1.83 per share, in comparison with $249.7 million, or $1.71 per share, final 12 months. Adjusted EPS grew 17% YoY to $3.44.
For full-year 2025, the corporate expects complete income to say no by a mid-single digit proportion at fixed forex versus full-year 2024. Adjusted EPS is predicted to be $15.25-16.25.
Prior efficiency
